Report Detail
Global Soluble Guanylate Cyclase Market Insights, Forecast to 2025
- RnM2897126 |
- 16 February, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
The global Soluble Guanylate Cyclase market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Soluble Guanylate Cyclase market based on company, product type, end user and key regions.
This report studies the global market size of Soluble Guanylate Cyclase in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Soluble Guanylate Cyclase in these regions.
This research report categorizes the global Soluble Guanylate Cyclase market by top players/brands, region, type and end user. This report also studies the global Soluble Guanylate Cyclase market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bayer AG
Boehringer Ingelheim GmbH
Ironwood Pharmaceuticals Inc
NicOx SA
SynZyme Technologies LLC
Topadur Pharma AG
Market size by Product
BAY-1636183
BI-703704
Hydroxyurea
IW-1701
Others
Market size by End User
Cardiovascular
Ophthalmology
Metabolic Disorders
Gastrointestinal
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Soluble Guanylate Cyclase market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Soluble Guanylate Cyclase market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Soluble Guanylate Cyclase companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Soluble Guanylate Cyclase submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Soluble Guanylate Cyclase are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Soluble Guanylate Cyclase market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Soluble Guanylate Cyclase Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Soluble Guanylate Cyclase Market Size Growth Rate by Product
- 1.4.2 BAY-1636183
- 1.4.3 BI-703704
- 1.4.4 Hydroxyurea
- 1.4.5 IW-1701
- 1.4.6 Others
- 1.5 Market by End User
- 1.5.1 Global Soluble Guanylate Cyclase Market Size Growth Rate by End User
- 1.5.2 Cardiovascular
- 1.5.3 Ophthalmology
- 1.5.4 Metabolic Disorders
- 1.5.5 Gastrointestinal
- 1.5.6 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Soluble Guanylate Cyclase Market Size
- 2.1.1 Global Soluble Guanylate Cyclase Revenue 2014-2025
- 2.1.2 Global Soluble Guanylate Cyclase Sales 2014-2025
- 2.2 Soluble Guanylate Cyclase Growth Rate by Regions
- 2.2.1 Global Soluble Guanylate Cyclase Sales by Regions
- 2.2.2 Global Soluble Guanylate Cyclase Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Soluble Guanylate Cyclase Sales by Manufacturers
- 3.1.1 Soluble Guanylate Cyclase Sales by Manufacturers
- 3.1.2 Soluble Guanylate Cyclase Sales Market Share by Manufacturers
- 3.1.3 Global Soluble Guanylate Cyclase Market Concentration Ratio (CR5 and HHI)
- 3.2 Soluble Guanylate Cyclase Revenue by Manufacturers
- 3.2.1 Soluble Guanylate Cyclase Revenue by Manufacturers (2014-2019)
- 3.2.2 Soluble Guanylate Cyclase Revenue Share by Manufacturers (2014-2019)
- 3.3 Soluble Guanylate Cyclase Price by Manufacturers
- 3.4 Soluble Guanylate Cyclase Manufacturing Base Distribution, Product Types
- 3.4.1 Soluble Guanylate Cyclase Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Soluble Guanylate Cyclase Product Type
- 3.4.3 Date of International Manufacturers Enter into Soluble Guanylate Cyclase Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Soluble Guanylate Cyclase Sales by Product
- 4.2 Global Soluble Guanylate Cyclase Revenue by Product
- 4.3 Soluble Guanylate Cyclase Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Soluble Guanylate Cyclase Breakdown Data by End User
6 North America
- 6.1 North America Soluble Guanylate Cyclase by Countries
- 6.1.1 North America Soluble Guanylate Cyclase Sales by Countries
- 6.1.2 North America Soluble Guanylate Cyclase Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Soluble Guanylate Cyclase by Product
- 6.3 North America Soluble Guanylate Cyclase by End User
7 Europe
- 7.1 Europe Soluble Guanylate Cyclase by Countries
- 7.1.1 Europe Soluble Guanylate Cyclase Sales by Countries
- 7.1.2 Europe Soluble Guanylate Cyclase Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Soluble Guanylate Cyclase by Product
- 7.3 Europe Soluble Guanylate Cyclase by End User
8 Asia Pacific
- 8.1 Asia Pacific Soluble Guanylate Cyclase by Countries
- 8.1.1 Asia Pacific Soluble Guanylate Cyclase Sales by Countries
- 8.1.2 Asia Pacific Soluble Guanylate Cyclase Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Soluble Guanylate Cyclase by Product
- 8.3 Asia Pacific Soluble Guanylate Cyclase by End User
9 Central & South America
- 9.1 Central & South America Soluble Guanylate Cyclase by Countries
- 9.1.1 Central & South America Soluble Guanylate Cyclase Sales by Countries
- 9.1.2 Central & South America Soluble Guanylate Cyclase Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Soluble Guanylate Cyclase by Product
- 9.3 Central & South America Soluble Guanylate Cyclase by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Soluble Guanylate Cyclase by Countries
- 10.1.1 Middle East and Africa Soluble Guanylate Cyclase Sales by Countries
- 10.1.2 Middle East and Africa Soluble Guanylate Cyclase Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Soluble Guanylate Cyclase by Product
- 10.3 Middle East and Africa Soluble Guanylate Cyclase by End User
11 Company Profiles
- 11.1 Bayer AG
- 11.1.1 Bayer AG Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Bayer AG Soluble Guanylate Cyclase Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Bayer AG Soluble Guanylate Cyclase Products Offered
- 11.1.5 Bayer AG Recent Development
- 11.2 Boehringer Ingelheim GmbH
- 11.2.1 Boehringer Ingelheim GmbH Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Boehringer Ingelheim GmbH Soluble Guanylate Cyclase Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Boehringer Ingelheim GmbH Soluble Guanylate Cyclase Products Offered
- 11.2.5 Boehringer Ingelheim GmbH Recent Development
- 11.3 Ironwood Pharmaceuticals Inc
- 11.3.1 Ironwood Pharmaceuticals Inc Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Ironwood Pharmaceuticals Inc Soluble Guanylate Cyclase Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Ironwood Pharmaceuticals Inc Soluble Guanylate Cyclase Products Offered
- 11.3.5 Ironwood Pharmaceuticals Inc Recent Development
- 11.4 NicOx SA
- 11.4.1 NicOx SA Company Details
- 11.4.2 Company Business Overview
- 11.4.3 NicOx SA Soluble Guanylate Cyclase Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 NicOx SA Soluble Guanylate Cyclase Products Offered
- 11.4.5 NicOx SA Recent Development
- 11.5 SynZyme Technologies LLC
- 11.5.1 SynZyme Technologies LLC Company Details
- 11.5.2 Company Business Overview
- 11.5.3 SynZyme Technologies LLC Soluble Guanylate Cyclase Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 SynZyme Technologies LLC Soluble Guanylate Cyclase Products Offered
- 11.5.5 SynZyme Technologies LLC Recent Development
- 11.6 Topadur Pharma AG
- 11.6.1 Topadur Pharma AG Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Topadur Pharma AG Soluble Guanylate Cyclase Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Topadur Pharma AG Soluble Guanylate Cyclase Products Offered
- 11.6.5 Topadur Pharma AG Recent Development
12 Future Forecast
- 12.1 Soluble Guanylate Cyclase Market Forecast by Regions
- 12.1.1 Global Soluble Guanylate Cyclase Sales Forecast by Regions 2019-2025
- 12.1.2 Global Soluble Guanylate Cyclase Revenue Forecast by Regions 2019-2025
- 12.2 Soluble Guanylate Cyclase Market Forecast by Product
- 12.2.1 Global Soluble Guanylate Cyclase Sales Forecast by Product 2019-2025
- 12.2.2 Global Soluble Guanylate Cyclase Revenue Forecast by Product 2019-2025
- 12.3 Soluble Guanylate Cyclase Market Forecast by End User
- 12.4 North America Soluble Guanylate Cyclase Forecast
- 12.5 Europe Soluble Guanylate Cyclase Forecast
- 12.6 Asia Pacific Soluble Guanylate Cyclase Forecast
- 12.7 Central & South America Soluble Guanylate Cyclase Forecast
- 12.8 Middle East and Africa Soluble Guanylate Cyclase Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Soluble Guanylate Cyclase Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Soluble Guanylate Cyclase . Industry analysis & Market Report on Soluble Guanylate Cyclase is a syndicated market report, published as Global Soluble Guanylate Cyclase Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Soluble Guanylate Cyclase market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
